Connect with us
Moderna agreed to sell its coronavirus drug at a "pandemic price" of $32-37 per dose.The biotech company registered losses of $240 million in the first half...
The clinical trial, led by the Catholic University, together with other universities and the Sinovac Biotech laboratory, already has funding from the public sector, the Confederation...
In March, BioNTech's share price, after rallying to $105, plummeted in two stages to initially $43.66 and then, after an interim recovery to $64.45, to $37....
The recent COVID-19 pandemic has brought together several biotech companies from around the world in an unprecedented effort to find a COVID-19 vaccine that would save...
As the new coronavirus spreads in the world, a number of biotech and pharmaceutical companies are working hard to meet challenges and develop vaccines. There are...
The pharmaceutical and biotechnology industry managers were invited to visit the White House, by the U.S. president, to discuss the development of possible strategies for the...
